S&P ASX All Technology

US Dollar vs AUD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

ANIX Anixa Biosciences Inc

3.03

0.22 (7.83%)

Last Updated: 04:30:19

Delayed by 15 minutes

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Anixa Biosciences (NASDAQ:ANIX)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Anixa Biosciences Charts.

Anixa Biosciences (NASDAQ:ANIX)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Anixa Biosciences Charts.

Anixa Biosciences Inc News

Anixa Biosciences CEO Provides Letter to Shareholders
Wednesday 22 January 2025 (1 day ago) • PR Newswire (US)

Form S-8 - Securities to be offered to employees in employee benefit plans
Saturday 11 January 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Saturday 11 January 2025 (2 weeks ago) • Edgar (US Regulatory)

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Saturday 4 January 2025 (3 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 4 January 2025 (3 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 4 January 2025 (3 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 4 January 2025 (3 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 4 January 2025 (3 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 4 January 2025 (3 weeks ago) • Edgar (US Regulatory)

Anixa Biosciences to Present at the iAccess Alpha Virtual Best Ideas Winter Conference 2024 on December 10
Thursday 5 December 2024 (2 months ago) • PR Newswire (US)

Anixa Biosciences Board of Directors Approves Purchase of Bitcoin as Treasury Reserve Asset
Saturday 23 November 2024 (2 months ago) • PR Newswire (US)

Anixa Biosciences Initiates Dosing in Third Cohort in its Ovarian Cancer CAR-T Clinical Trial
Tuesday 19 November 2024 (2 months ago) • PR Newswire (US)

More Anixa Biosciences Inc News Articles

Woodside Petroleum

Australia And New Zealan...

Newcrest Mining

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions